Publications

Publications

WHO/Victor Garstea
© Credits

Latest publications

All →
Country deep dive on the well-being economy: Scotland

The WHO Regional Office for Europe’s series of deep dives are part of the technical documentation supporting the WHO European Regional High-level...

Ukraine: 2026 Summer risk assessment

As Ukraine approaches the summer of 2026, the health sector is operating under the dual pressure of prolonged war and intensifying climate-related risks....

Situational analysis of hypertension in Ukraine 2025

This situational analysis examines the burden, management and system response to hypertension in Ukraine, where elevated blood pressure is a leading contributor...

WHO Country Cooperation Strategy: Belgium, 2026–2030

The WHO Country Cooperation Strategy: Belgium, 2026–2030 sets the framework for collaboration between Belgium and the WHO for the next 5 years, aligning...



Latest documents

All →

Tuberculosis and malnutrition factsheet

Overview

TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally. Malnutrition has significant interactions with the TB disease process and may be an important therapeutic target. There is a bidirectional relationship between TB and malnutrition: malnourished individuals are at greater risk of contracting TB, and TB is a catabolic disease that can cause or exacerbate malnutrition. TB patients who are malnourished experience poorer outcomes, which are more pronounced in those with RR/MDR-TB. Malnutrition impairs immune system function in multiple ways, and this may underpin some of the observed relationships. Furthermore, malnutrition can influence how drugs are absorbed and processed, causing treatment failure and downstream effects on treatment toxicity rates in TB patients.

WHO Team
Special Initiative on NCDs and Innovation (SNI)
Number of pages
10